Anemocyte will participate in the international BIO-Europe Spring conference in Milan

Anemocyte will participate in the international BIO-Europe Spring conference in Milan

Bio Europe Spring Event pharmaceutical sector

The international BIO-Europe Spring® conference is now in its 19th year and this year will take place in Milan at Allianz MiCo from March 17-19, 2025.

Anemocyte will be present during the three-day event: the event will bring together life science leaders through one-on-one meetings, company presentations and strategic discussions.

BIO-Europe Spring 2025 will address key issues in the biopharma industry through networking meetings and workshops.

The first day will be dedicated to partnering between companies and investors, with insights on effective presentations and biotech investments with a global focus. The second day will explore the impact of Asian innovation in the pharmaceutical sector, analyzing new trends in biotechnology, licensing strategies and international collaborations.
Finally, the third day will include additional partnering meetings and presentations on cell screening platforms and AI simulations for drug development.

You can book an appointment with Anemocyte through the partnering platform partneringONE®.

This event offers a unique opportunity to connect with cutting-edge life science companies and will be a chance to build and strengthen strategic relationships in the biotech and pharmaceutical industries.

We look forward to seeing you at the Allianz MiCo convention center from March 17-19, 2025.

2500 1875 Anemocyte.com

Anemocyte S.r.l. Single Shareholder Private Limited-Liability Company
Via R. Lepetit, 34 21040 Gerenzano (VA) Italy | Ph: +39 02 99372311 – Fax: +39 02 99372313 | Anemocyte Inc. 1221 Brickell Avenue, Suite 1160 Miami FL 33131

VAT number: 12914940155 | Share capital € 530.000,00 fully paid | R.E.A. 276961